Unichem Pharmaceuticals USA Inc. recalls Doxazosin Tablets
- Published
- 18 Feb 2026
- Units affected
- 60,000 tablets
- Agency
- FDA
- Country
- United States
The hazard
Tablets/Capsules Imprinted with Wrong ID
Classification: Class III — this product is unlikely to cause health problems but breaks FDA rules (for example labeling).
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, distributed by Unichem Pharmaceuticals (USA), Inc., 1 Tower Center Boulevard, Suite 2200, East Brunswick, NJ 08816 USA, manufactured by Unichem Laboratories Limited, Plot Number 15 to 18, Pilerne Industrial Estate, Pilerne, Bardez, Goa (India) 403511, NDC 29300-353-10.
- Brand / company
- Unichem Pharmaceuticals USA Inc.
- Codes / lots
- Lot # GDSH25006, Exp Date: 08/2027
- Distribution
- Nationwide
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 18 Feb 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.